These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31107862)

  • 1. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.
    Fernandez-Cooke E; Barrios Tascón A; Sánchez-Manubens J; Antón J; Grasa Lozano CD; Aracil Santos J; Villalobos Pinto E; Clemente Garulo D; Mercader Rodríguez B; Bustillo Alonso M; Nuñez Cuadros E; Navarro Gómez ML; Domínguez-Rodríguez S; Calvo C;
    PLoS One; 2019; 14(5):e0215665. PubMed ID: 31107862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
    Edraki MR; Mohammadi H; Mehdizadegan N; Ghorashi M; Amoozgar H; Borzouee M; Ajami G; Keshavarz K; Dehghani E; Bahrami R
    Arch Iran Med; 2020 Jan; 23(1):31-36. PubMed ID: 31910632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    Fabi M; Corinaldesi E; Pierantoni L; Mazzoni E; Landini C; Bigucci B; Ancora G; Malaigia L; Bodnar T; Di Fazzio G; Lami F; Valletta E; Cicero C; Biasucci G; Iughetti L; Marchetti F; Sogno Valin P; Amarri S; Brusa S; Sprocati M; Maggiore G; Dormi A; Lanzoni P; Donti A; Lanari M
    PLoS One; 2018; 13(9):e0202658. PubMed ID: 30180185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective cohort study of major adverse cardiac events in children affected by Kawasaki disease with coronary artery aneurysms in Thailand.
    Santimahakullert K; Vijarnsorn C; Wongswadiwat Y; Chanthong P; Khrongsrattha S; Panamonta M; Chan-On P; Durongpisitkul K; Chungsomprasong P; Kanjanauthai S; Soongswang J
    PLoS One; 2022; 17(1):e0263060. PubMed ID: 35085339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Kawasaki Disease: A Single-Center Experience.
    Uysal F; Bostan OM; Celebi S; Uysal B; Hamitoglu S; Cil E
    Clin Pediatr (Phila); 2015 Jun; 54(6):579-84. PubMed ID: 25475592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
    Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD; Lin YT; Tsai ZY; Chang LS; Liu SF; Lin YJ; Kuo HC
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):46. PubMed ID: 31324255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP; Yan WL; Huang M; Huang MR; Chen S; Huang GY; Liu F
    J Epidemiol; 2020 Oct; 30(10):429-435. PubMed ID: 31548437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns.
    Sadeghi P; Izadi A; Mojtahedi SY; Khedmat L; Jafari M; Afshin A; Yarahmadi P; Hosseinali Beigi E
    BMC Infect Dis; 2021 Apr; 21(1):368. PubMed ID: 33874899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kawasaki disease in Iceland 1996-2005, epidemiology and complications].
    Olafsdottir HS; Oskarsson G; Haraldsson Á
    Laeknabladid; 2012 Feb; 98(2):91-5. PubMed ID: 22314510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.